Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lttl vs Teladoc Health

Lttl
Graded #204

Higher grade

vs+10.199999999999996
Teladoc Health
Graded #428

Lower grade

The verdict

Lttl takes it — 66.1/100 to 55.9/100.

Lttl grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lttl (pronounced 'little') is a direct-to-consumer telehealth brand offering compounded semaglutide and tirzepatide, a low-dose 'microdose' line, and longevity peptides.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLttl +11
56
45
Dose & formulationLttl +56
96
40
Clinical oversightTeladoc Health +1
76
77
Labs & monitoringTeladoc Health +9
52
61
FulfillmentLttl +5
69
64
Contract termsTeladoc Health +35
20
55
Lttl · left barTeladoc Health · right bar

The numbers

MetricLttlTeladoc Health
WeighScore66.1/10055.9/100
GradeCC
Scorecard rank#204#428
Semaglutide$199/mo (all doses, compounded)Not disclosed
Tirzepatide$279/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Lttl

Graded #204 · C

Strengths

  • Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
  • Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
  • States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
  • Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
  • Oral ODT semaglutide offered for members who want to avoid injections

Where it loses points

  • Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
  • The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
  • No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
  • Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
  • Medications cannot be returned or refunded once they ship from the pharmacy
Teladoc Health

Graded #428 · C

Strengths

  • Dedicated GLP-1 Prescription and Support program for weight management
  • Backed by one of the largest virtual care companies in the US
  • Partners with 50%-plus of Fortune 500 and 100-plus health plans
  • Adds nutrition, coaching and connected device tracking
  • Strong clinical credibility and brand trust

Where it loses points

  • Distributed mainly via employers and health plans, limited direct cash-pay
  • No transparent published monthly price for GLP-1 care
  • Specific medications and eligibility vary by plan coverage
  • Member experience can depend on the employer's chosen configuration

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard